Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
129 studies found for:    caregivers and alzheimer's | United States, Florida
Show Display Options
Rank Status Study
1 Completed Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
2 Completed
Has Results
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Dementia of the Alzheimer's Type
Interventions: Drug: memantine ER;   Drug: Placebo
3 Completed
Has Results
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol;   Drug: Memantine;   Drug: Placebo
4 Terminated
Has Results
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Dimebon 20 mg po TID;   Drug: Placebo po TID
5 Completed Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone Extended Release 2mg;   Drug: Rosiglitazone Extended Release 8mg;   Other: Placebo;   Other: Donepezil;   Other: Galantamine;   Other: Rivastigmine
6 Completed
Has Results
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg;   Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 200 mg/kg;   Biological: Placebo solution: Human Albumin 0.25% - 4 mL/kg;   Biological: Placebo solution: Human Albumin 0.25% - 2 mL/kg
7 Completed Coordinating Center for Caregiver Intervention Trial
Conditions: Dementia;   Alzheimer Disease
Intervention: Procedure: multicomponent psychosocial intervention
8 Completed Coordinating Center for Enhancing ADRD Caregiving
Conditions: Dementia;   Alzheimer Disease
Interventions: Procedure: Skill Training Condition – problem solving training;   Procedure: REACH for TLC (Telephone Linked Computer) system
9 Completed Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
10 Enrolling by invitation Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: EVP-6124
11 Completed Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone
12 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
13 Completed ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
Condition: Alzheimer's Disease
Intervention: Drug: VP4896
14 Completed Effect of Different Doses of SAR110894D on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D;   Drug: placebo
15 Completed Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Donepezil;   Drug: AZD3480
16 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
17 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
18 Terminated Phase 3 IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution;   Biological: Human albumin 0.25%
19 Unknown  Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Other: Gastro-retentive zinc cysteine tablet;   Other: Tablet identical physically to active comparator containing some lactose
20 Completed CATIE-Alzheimer's Disease Trial
Condition: Alzheimer's Disease
Interventions: Drug: Olanzapine;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Citalopram

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years